ERBB2 and breast cancer: ER− and HER2+ BC biopsies were infiltrated with more IL-17A-producing immune cells primarily comprising of lymphocytes and macrophages than ER+ BC biopsies (Chen et al., 2013; Cochaud et al., 2013).